Clinical Trials Directory

Trials / Sponsors / Angion Biomedica Corp

Angion Biomedica Corp

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
UnknownStudy to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF)
Phase 12022-06-01
UnknownStudy of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
Glomerular Disease, Proteinuria
Phase 22021-12-24
UnknownStudy to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects
Hemodialysis
Phase 12021-07-01
UnknownStudy Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval
Healthy Volunteer
Phase 12021-06-01
UnknownA Study to Assess the Absorption, Metabolism and Excretion of [14C]-ANG-3777
Healthy
Phase 12021-05-21
UnknownStudy to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia
COVID-19, Pneumonia
Phase 22020-07-31
CompletedANG-3070 in Healthy Adult Participants
Healthy Volunteers
Phase 12019-12-17
UnknownStudy to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass
Acute Kidney Injury
Phase 22017-02-24
UnknownReduce the Severity of DGF in Recipients of a Deceased Donor Kidney
Delayed Graft Function
Phase 32016-03-01
TerminatedStudy to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
Myocardial Infarction
Phase 22012-07-01
UnknownStudy on Delayed Graft Function Using Paired Kidneys
Delayed Graft Function
Phase 22011-08-01
UnknownStudy to Improve Renal Function After Kidney Transplantation
Delayed Graft Function
Phase 22010-02-01